Guillermo Yudowski to Endocannabinoids
This is a "connection" page, showing publications Guillermo Yudowski has written about Endocannabinoids.
Connection Strength
0.335
-
Delgado-Peraza F, Ahn KH, Nogueras-Ortiz C, Mungrue IN, Mackie K, Kendall DA, Yudowski GA. Mechanisms of Biased ?-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor. Mol Pharmacol. 2016 06; 89(6):618-29.
Score: 0.133
-
Flores-Otero J, Ahn KH, Delgado-Peraza F, Mackie K, Kendall DA, Yudowski GA. Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1. Nat Commun. 2014 Aug 01; 5:4589.
Score: 0.119
-
Pardo-Garc?a TR, Yusif-Rodriguez N, Yudowski G, Maldonado-Vlaar CS. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats. Neurosci Lett. 2020 07 27; 732:135023.
Score: 0.044
-
Jagla CAD, Scott CE, Tang Y, Qiao C, Mateo-Semidey GE, Yudowski GA, Lu D, Kendall DA. Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate ?-Arrestin-Dependent Responses. Mol Pharmacol. 2019 01; 95(1):1-10.
Score: 0.040